We are live on ! Find out more
LAB icon

Standard BioTools
LAB

106 hedge funds and large institutions have $306M invested in Standard BioTools in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $20M | Put options by funds: $9.99M

22% more capital invested

Capital invested by funds: $252M → $306M (+$54.2M)

3% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 30

3% less funds holding

Funds holding: 109 → 106 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
106
Holders Change
-3
Holders Change %
-2.75%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
29
Reduced
30
Closed
22
Calls
$20M
Puts
$9.99M
Net Calls
+$9.99M
Net Calls Change
+$4.85M

Top Buyers

1
CWAM
Columbia Wanger Asset Management
Illinois
+$17.6M
2
BIM
Bogle Investment Management
Massachusetts
+$2.03M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$2.01M
4
SCM
Scopia Capital Management
New York
+$1.97M
5
Goldman Sachs
Goldman Sachs
New York
+$1.57M

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$16.2M
2
Franklin Resources
Franklin Resources
California
-$7.43M
3
EAM
EverPoint Asset Management
Connecticut
-$7.3M
4
SM
Sabby Management
Florida
-$3.58M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$141K -$15K -1,523 -10%
BA
77
BlackRock Advisors
Delaware
$132K -$64.5K -6,568 -35%
BCM
78
Bayesian Capital Management
New York
$121K +$109K +11,149 New
UBS AM
79
UBS AM
Illinois
$109K – – –
WMSA
80
Weiss Multi-Strategy Advisers
New York
$108K – – –
PAM
81
Panagora Asset Management
Massachusetts
$97K +$72K +7,337 +439%
Citigroup
82
Citigroup
New York
$96K +$86.3K +8,791 +11,567%
BG
83
BlackRock Group
United Kingdom
$87K -$2.16K -220 -3%
HCM
84
Highlander Capital Management
New Jersey
$65K -$19.6K -2,000 -25%
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
$61.5K -$1.87K -190 -3%
Legal & General Group
86
Legal & General Group
United Kingdom
$47K – – –
UBS Group
87
UBS Group
Switzerland
$34K -$38.7K -3,945 -55%
Teacher Retirement System of Texas
88
Teacher Retirement System of Texas
Texas
$28K -$8.94K -910 -26%
Morgan Stanley
89
Morgan Stanley
New York
$27K -$72.9K -7,425 -75%
Simplex Trading
90
Simplex Trading
Illinois
$19K -$29.7K -3,025 -63%
Canada Life
91
Canada Life
Manitoba, Canada
$19K – – –
SEI Investments
92
SEI Investments
Pennsylvania
$15K +$13.5K +1,376 +137,600%
Bank of America
93
Bank of America
North Carolina
$9K -$573K -58,345 -99%
BlackRock
94
BlackRock
New York
$7K – – –
MFW
95
Mosaic Family Wealth
Missouri
$7K +$6.87K +700 New
SIM
96
Sonora Investment Management
Arizona
$5K – – –
Bank of Montreal
97
Bank of Montreal
Ontario, Canada
$5K +$4.36K +444 New
Zurich Cantonal Bank
98
Zurich Cantonal Bank
Switzerland
$4K – – –
US Bancorp
99
US Bancorp
Minnesota
$3K – – –
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
$2K – – –
2 3
4
5 6

LAB Hedge Fund Activity: Q4 2015 in Review

106 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2015, worth a combined $306M — up 22% from $252M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 19 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 29 added.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $17.6M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $16.2M sold.

  • 106 institutional investors held Standard BioTools (LAB) as of Q4 2015, down from 109 in Q3 2015.
  • Funds reported $306M of Standard BioTools stock for Q4 2015, up 22% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q4 2015 and 22 closed out, a net change of -3 holders.
  • The largest Standard BioTools buyer in Q4 2015 was Columbia Wanger Asset Management, an estimated $17.6M added.
  • The largest Standard BioTools seller in Q4 2015 was JP Morgan Chase, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2015.